Medtronic has reported its best quarter in 2.5 years, but the impact of tariffs on its profit is still being felt. The company's performance is being closely watched, with some outlets discussing its potential for growth and others noting challenges, including those related to chinese value-based purchasing. However, there is some uncertainty, as Medtronic's stock is also reported to be sinking, suggesting a potentially mixed outlook.